HCW Biologics wins key U.S. patent protection for hair loss drug
HCW Biologics received a Notice of Allowance from the U.S. Patent and Trademark Office for claims directed to the use of HCW9302 to treat alopecia areata. Together with four recently issued U.S. patents (Nos. 11,401,326; 11,987,619; 12,018,071; 12,516,112) covering compositions, nucleic acids encodi
<p>HCW Biologics received a Notice of Allowance from the U.S. Patent and Trademark Office for claims directed to the use of HCW9302 to treat alopecia areata. Together with four recently issued U.S. patents (Nos. 11,401,326; 11,987,619; 12,018,071; 12,516,112) covering compositions, nucleic acids encodi</p>